AstraZeneca plc
Time frame: 1 June 2023 - 31 May 2024Article ‘Count’ and ‘Share’ for AstraZeneca plc based on listed parameters only.
The articles listed below published by authors from AstraZeneca plc, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.02 |
Cancer Cell |
2 | 0.20 |
Cancer Research |
1 | 0.86 |
Developmental Cell |
1 | 0.20 |
Journal of Biological Chemistry |
3 | 1.70 |
Journal of Cell Biology |
1 | 0.50 |
Journal of Clinical Investigation |
3 | 1.39 |
Journal of Neuroscience |
1 | 0.18 |
Molecular Cell |
3 | 0.46 |
Nature |
4 | 0.99 |
Nature Chemical Biology |
1 | 0.09 |
Nature Communications |
32 | 12.16 |
Nature Genetics |
3 | 0.17 |
Nature Immunology |
2 | 0.26 |
PLOS Genetics |
1 | 0.17 |
Proceedings of the National Academy of Sciences of the United States of America |
3 | 1.18 |
Science |
1 | 0.01 |
Science Advances |
6 | 1.22 |
Science Translational Medicine |
4 | 0.42 |
The EMBO Journal |
3 | 0.40 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.